Ipsen is a global biopharmaceutical Group dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. We also have a well-established and successful Consumer Healthcare business. We are committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.
The Group was founded in 1929 and, by its 91th anniversary, operates in 37 countries, with about 5.7 thousand employees worldwide.
Ipsen has been present in Russia since 1993, here are 10 of the company's drugs used in general therapeutic practice, in the field of Specialty Care, including aesthetic medicine. The company has about 300 employees.
Russia leads the Ipsen cluster in the CIS, consisting of 10 countries.